Newsletter

Harris Corporation Awarded $1.5 Billion in US Geospatial Intelligence Contracts

On July 10, Harris Corporation (HRS) reported that the company has been awarded three multi-award IDIQ contracts by the National Geospatial-Intelligence Agency (NGA). Harris will create, manage, and distribute high-quality geospatial intelligence for the US intelligence community and military. The contract covers services for up to 10 years and totals $1.5 billion.   Sonal sent […]

Read more...

Aclaris Therapeautics Reports Positive Phase 2 Clinical Trial Results

On June 28, Aclaris Therapeutics (ACRS) reported positive interim results from its Phase 2 clinical trial of AA-202 Topical. The drug is an investigational topical to treat two of the more severe variants of Alopecia Areata. Patients did not experience any treatment-related serious adverse events, and results for the full patient sample will be reported […]

Read more...

IsoRay Receives FDA 510(k) Clearance for GammaTileTM Therapy

On July 9, IsoRay, Inc. (ISR) and GT Medical Technologies, Inc. announced they received FDA 510(k) regulatory clearance for their brachytherapy technology, known as GammaTileTMTherapy. The therapy incorporates proprietary Cesium-131 seeds within customizable collagen-based carriers to treat recurrent brain tumors. The two companies previously executed a ten-year collaborative development agreement.   Sonal detected the event […]

Read more...

AZZ Awarded Contract in China as part of Highest Transmission Capacity Project in the World

AZZ, Inc. (AZZ) announced on June 29 that the company was awarded a contract in the People’s Republic of China to produce approximately 7,431 meters of Ultra High Voltage 1100KV Gas Insulated Line for the Cross Yangtze River Sutong Underground Tunnel Project. The contract is with SDEE Hitachi High Voltage Switchgear and Pinggao Group Company […]

Read more...

June 2018 Scorecard

The June 2018 scorecard for the signals generated from Sonal can be downloaded here. For more information regarding how you can trade these signals, see the article The Three Moves for Event Based Trading Try Sonal 30 days for free and cancel anytime! Subscribe here and check out the Quickstart Guide FacebookGoogle+Twitter

Read more...

Upland Software Acquires RO Innovation and Increases Earnings Guidance

On June 18, Upland Software, Inc. (UPLD) announced that the company completed its acquisition of RO Innovation, owner of a leading cloud-based customer reference solution. The system will be integrated into Upland’s Qvidian system, a cloud-based RFP management system. Upland expects the acquisition will generate an extra $6 million in revenue, of which $5 million […]

Read more...

Zafgen Reports Positive Phase 2 Clinical Trial Results for ZGN-1061

On June 23, Zafgen, Inc. (ZFGN) reported positive results from the company’s Phase 2 clinical trial of ZGN-1061. The trial is designed to prove the drug’s efficacy and safety in patients with type 2 diabetes and to establish a minimally effective dose. Zafgen reported that the patients had no treatment-related serious adverse events.   Sonal alerted […]

Read more...

Blue Bird Announces Share Repurchase Program

Blue Bird Corporation (BLBD) announced on June 13 that the company’s Board of Directors authorized a new share repurchase program. The company’s previous $50 million share repurchase program closed in March 2018. Under the new program, the company can repurchase up to $25 million in outstanding common stock or series A convertible preferred stock over […]

Read more...